In particular, PSMA-PET shows much promise for the identification of local tumor recurrence in patients with a rising prostate-specific antigen (PSA) status post radical prostatectomy in whom conventional imaging would otherwise be of limited sensitivity. The gene discussed is KLK3; the disease is neoplasm.